agilon health inc. (NYSE: AGL) is 22.43% higher on its value in year-to-date trading and has touched a low of $14.36 and a high of $28.36 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The AGL stock was last observed hovering at around $20.50 in the last trading session, with the day’s loss setting it -0.74% off its average median price target of $26.00 for the next 12 months. It is also 51.8% off the consensus price target high of $41.00 offered by 15 analysts, but current levels are 5.9% higher than the price target low of $21.00 for the same period.
Currently trading at $19.76, the stock is 11.07% and 12.82% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.36 million and changing -3.61% at the moment leaves the stock -4.77% off its SMA200. AGL registered 21.08% gain for a year compared to 6-month loss of -21.37%.
The stock witnessed a 17.20% gain in the last 1 month and extending the period to 3 months gives it a -1.94%, and is 0.00% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.52% over the week and 4.56% over the month.
agilon health inc. (AGL) has around 648 employees, a market worth around $7.89B and $2.48B in sales. Profit margin for the company is -4.30%. Distance from 52-week low is 37.60% and -30.32% from its 52-week high. The company has generated returns on investments over the last 12 months (-34.60%).
agilon health inc. (AGL) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for agilon health inc. (AGL) is a “Buy”. 15 analysts offering their recommendations for the stock have an average rating of 1.60, where 1 rate it as a Hold and 0 think it is a “Overweight”. 14 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
agilon health inc. is expected to release its quarterly report on 05/24/2023.The EPS is expected to shrink by -560.10% this year.
agilon health inc. (AGL) Top Institutional Holders
The shares outstanding are 411.06M, and float is at 407.24M with Short Float at 6.80%.
agilon health inc. (AGL) Insider Activity
A total of 69 insider transactions have happened at agilon health inc. (AGL) in the last six months, with sales accounting for 36 and purchases happening 33 times. The most recent transaction is an insider sale by Kornitzer Benjamin,the company’sChief Med. & Quality Officer. SEC filings show that Kornitzer Benjamin sold 5,396 shares of the company’s common stock on Jan 20 at a price of $19.92 per share for a total of $0.11 million. Following the sale, the insider now owns 10426.0 shares.
agilon health inc. disclosed in a document filed with the SEC on Jan 19 that Kornitzer Benjamin (Chief Med. & Quality Officer) sold a total of 10,792 shares of the company’s common stock. The trade occurred on Jan 19 and was made at $19.73 per share for $0.21 million. Following the transaction, the insider now directly holds 10426.0 shares of the AGL stock.
Still, SEC filings show that on Jan 18, Shaker Benjamin (Chief Markets Officer) disposed off 20,723 shares at an average price of $19.78 for $0.41 million. The insider now directly holds 25,625 shares of agilon health inc. (AGL).